ARCHIVES

Treatment Progress Stirs Up Big ASCO turnout; Reports Presented

This article is from The Cancer Letter archive.

Vol. 02 No. 20 | May 14, 1976

Download PDF Visit The Full Archive

Related Articles

ASCO 2011 Award Winners

June 10, 2011

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

September 28, 2001

Phase III Avastin Trial Fails Primary Endpoints

February 28, 2014

Children’s Memorial Hospital Receives $3 Million Endowment From Price Trust

May 28, 2010

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

November 26, 2014